AnPac Bio-Medical Science Co., Ltd. Made Headway

Mon, Aug 22, 2022 at 06:55 PM

AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) soared at $0.36, representing a gain of 66%. On Mon, Aug 22, 2022, ANPC:NASDAQ touched a New 2-Week High of $0.36. From Mon, Aug 08, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days

The stock spiked on Mon, Aug 22, 2022 at $0.59 with a volume of 98M+.

About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)

AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.

Top 10 Gainers:

Bright Minds Biosciences Inc. (DRUG:NASDAQ), 72.8%
AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 66.01%
Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
Summit Therapeutics plc (SMMT:NASDAQ), 48.18%
Minerva Neurosciences, Inc. (NERV:NASDAQ), 47.83%
Wag! Group Co. (PET:NASDAQ), 47.01%
Bon Natural Life Limited (BON:NASDAQ), 36.45%
Signify Health Inc. Class A (SGFY:NYSE), 32.08%
Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 30.68%
Blue Apron Holdings, Inc. (APRN:NYSE), 26.34%